The purpose of the research was to study kinds, frequencies and features of heart rhythm disturbances (HRD) in patients with chronic obstructive pulmonary disease (COPD) subject to degree of severity, including presence of coronary heart disease (CHD). 1189 of patients with registered HRD were examined. 315 of them had COPD (group 1), 531--combination of COPD and CHD (group 2), 343 were CHD patients (group 3). The extent of examinations included electrocardiogram (ECG), Halter monitoring (HM), bicycle ergometry (BEM), external respiration function estimation. Supraventricular HRD were registered statistically more frequently in group 1: according to ECG data in rest - in 37.2% patients, by BEM results--in 18.8%, by HM--in 50%. Combined (supraventricular and ventricular) HRD were registered most frequently in group 2: 41.2 24.4, and 45.5% respectively. Ventricular HRD dominated in group 3: 47.6, 29.3 and 48.6% respectively. The results of the study indicate that supraventricular HRDprevaile in patients with COPD, combined HRD - in patients with COPD and CHD. Ventricular HRD, which most informatively reflect changes in intracardiac geometry and left ventricle hemodynamics, dominate in CHD patients. The optimization of therapy correction consists in early diagnostics of HRD subject to features of cardiorespiratory system functional state.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Relationship between transient ischemic dilatation and changes in heart rate during gated SPECT acquisition in a low-risk population without perfusion defects.
Nucl Med Commun
July 2024
Nuclear Medicine Service, Italian Hospital, Montevideo, Uruguay.
Objectives: Transient ischemic dilatation (TID) in myocardial perfusion single photon emission computed tomography (SPECT) is considered a marker of poor prognosis. However, it has been suggested that some cases are due to apparent volumetric changes secondary to differences in heart rate (HR) at the time of acquisition. We assessed the correlation between transient dilatation and HR in low risk patients with no perfusion defects.
View Article and Find Full Text PDFAnthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD).
ESMO Open
January 2024
Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo. Electronic address:
Article Synopsis
- The study focuses on the role of BRCA and other homologous recombination repair (HRR) genes in DNA damage repair in heart cells, particularly in breast cancer patients receiving anthracycline-based chemotherapy.
- In a cohort of 503 patients, those with pathogenic variants in BRCA or other HRR genes showed a significant decrease in heart function, measured by left ventricular ejection fraction (LVEF), after chemotherapy.
- The findings suggest that genetic mutations in HRR genes heighten the risk of heart toxicity from cancer treatment, indicating the need for careful monitoring in these patients.
Heart rate disorders in patients with Tako-tsubo syndrome.
Med Clin (Barc)
October 2023
Instituto Cardiovascular, Hospital Clínico San Carlos, Madrid, España; Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Villaviciosa de Odón, Madrid, España.
Article Synopsis
- * The research analyzed data from the National Registry of TTS, involving over 1,000 patients from various hospitals, highlighting patients with HRD experienced more complications, such as shock and infections, during hospitalization.
- * Findings indicate that patients with TTS and HRD tend to have worse long-term prognoses, including higher mortality rates and more adverse cardiac events, although the correlation was not statistically significant.
Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study.
Clin Cancer Res
December 2022
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai P.R. China.
Purpose: This prospective single-arm phase II clinical trial aimed to evaluate the efficacy and safety of pegylated liposomal doxorubicin (PLD) combined with ifosfamide (IFO) as the first-line treatment for patients with advanced or metastatic soft-tissue sarcoma (STS).
Patients And Methods: Patients received PLD (30 mg/m2; day 1) in combination with IFO (1.8 g/m2; days 1-5) every 21 days until disease progression, unacceptable toxicities, patient death, or for up to six cycles.
Prognostic value of discharge heart rate in acute heart failure patients: More relevant in atrial fibrillation?
Int J Cardiol Heart Vasc
February 2020
Cardiology Department, Complejo Hospital Universitario de Santiago, Santiago de Compostela, Spain.
Article Synopsis
- The study aimed to assess how heart rate at admission, discharge, and the difference between the two affects long-term outcomes in acute heart failure patients with either sinus rhythm or atrial fibrillation.
- It included 1398 patients and found that only the heart rate at discharge was linked to one-year mortality, with higher rates indicating a greater risk for both sinus rhythm and atrial fibrillation patients.
- The conclusions suggest that a lower discharge heart rate is associated with better long-term outcomes in these patients, while admission heart rate and the difference didn't show significant prognostic impact.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!